Matches in SemOpenAlex for { <https://semopenalex.org/work/W1936422345> ?p ?o ?g. }
- W1936422345 endingPage "300" @default.
- W1936422345 startingPage "294" @default.
- W1936422345 abstract "The antihypertensive agent diltiazem (DTZ) impairs hepatic drug metabolism by inhibition of cytochrome P450 (CYP). The accumulation of DTZ metabolites in serum occurs during prolonged therapy and leads to decreased DTZ elimination. Thus, DTZ metabolites may contribute to CYP inhibition. This study assessed the role of human CYPs in microsomal DTZ oxidation and the capacity of DTZ metabolites to inhibit specific CYP activities. DTZ N-demethylation varied 10-fold in microsomal fractions from 17 livers (0.33-3.31 nmol/mg of protein/min). DTZ oxidation was correlated with testosterone 6beta-hydroxylation (r = 0.82) and, to a lesser extent, tolbutamide hydroxylation (r = 0.59) but not with activities mediated by CYP1A2 or CYP2E1. CYP3A4 in lymphoblastoid cell microsomes catalyzed DTZ N-demethylation but CYP2C8 and CYP2C9 were also active (approximately 20% and 10% of the activity supported by CYP3A4); seven other CYPs produced little or no N-desmethyl DTZ from DTZ. The CYP3A4 inhibitors ketoconazole and troleandomycin decreased microsomal DTZ oxidation, but inhibitors or substrates of CYP2C, CYP2D and CYP2E1 produced no inhibition. Some inhibition was produced by alpha-naphthoflavone, a chemical that inhibits CYP1As and also interacts with CYP3A4. In further experiments, the capacities of DTZ and three metabolites to modulate human CYP 1A2, 2E1, 2C9 and 3A4 activities were evaluated in vitro. DTZ and its N-desmethyl and N,N-didesmethyl metabolites selectively inhibited CYP3A4 activity, whereas O-desmethyl DTZ was not inhibitory. The IC50 value of DTZ against CYP3A4-mediated testosterone 6beta-hydroxylation (substrate concentration, 50 microM) was 120 microM. The N-desmethyl (IC50 = 11 microM) and N,N-didesmethyl (IC50 = 0.6 microM) metabolites were 11 and 200 times, respectively, more potent. From kinetic studies, N-desmethyl DTZ and N,N-didesmethyl DTZ were potent competitive inhibitors of CYP3A4 (Ki = approximately 2 and 0.1 microM, respectively). CYP3A4 inhibition was enhanced when DTZ and N-desmethyl DTZ underwent biotransformation in NADPH-supplemented hepatic microsomes in vitro, supporting the contention that inhibitory metabolites may be generated in situ. These findings suggest that N-demethylated metabolites of DTZ may contribute to CYP3A4 inhibition in vivo, especially under conditions in which N-desmethyl DTZ accumulates, such as during prolonged DTZ therapy." @default.
- W1936422345 created "2016-06-24" @default.
- W1936422345 creator A5001634303 @default.
- W1936422345 creator A5003967548 @default.
- W1936422345 creator A5027935289 @default.
- W1936422345 creator A5089184763 @default.
- W1936422345 date "1997-07-01" @default.
- W1936422345 modified "2023-09-23" @default.
- W1936422345 title "Role of CYP3A4 in human hepatic diltiazem N-demethylation: inhibition of CYP3A4 activity by oxidized diltiazem metabolites." @default.
- W1936422345 cites W1525055187 @default.
- W1936422345 cites W1598163711 @default.
- W1936422345 cites W1623357808 @default.
- W1936422345 cites W1775749144 @default.
- W1936422345 cites W1808289268 @default.
- W1936422345 cites W182320622 @default.
- W1936422345 cites W1834946969 @default.
- W1936422345 cites W1888004082 @default.
- W1936422345 cites W1933372259 @default.
- W1936422345 cites W1950438587 @default.
- W1936422345 cites W1958017720 @default.
- W1936422345 cites W1977032098 @default.
- W1936422345 cites W1985866882 @default.
- W1936422345 cites W2001659679 @default.
- W1936422345 cites W2032421656 @default.
- W1936422345 cites W2041689832 @default.
- W1936422345 cites W2043708497 @default.
- W1936422345 cites W2051175552 @default.
- W1936422345 cites W2056196711 @default.
- W1936422345 cites W2059293500 @default.
- W1936422345 cites W2064314929 @default.
- W1936422345 cites W2069846556 @default.
- W1936422345 cites W2071905105 @default.
- W1936422345 cites W2076612050 @default.
- W1936422345 cites W2155268095 @default.
- W1936422345 cites W2163656142 @default.
- W1936422345 cites W2341990973 @default.
- W1936422345 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/9223567" @default.
- W1936422345 hasPublicationYear "1997" @default.
- W1936422345 type Work @default.
- W1936422345 sameAs 1936422345 @default.
- W1936422345 citedByCount "45" @default.
- W1936422345 countsByYear W19364223452013 @default.
- W1936422345 countsByYear W19364223452014 @default.
- W1936422345 countsByYear W19364223452015 @default.
- W1936422345 countsByYear W19364223452017 @default.
- W1936422345 countsByYear W19364223452018 @default.
- W1936422345 countsByYear W19364223452020 @default.
- W1936422345 countsByYear W19364223452021 @default.
- W1936422345 countsByYear W19364223452022 @default.
- W1936422345 crossrefType "journal-article" @default.
- W1936422345 hasAuthorship W1936422345A5001634303 @default.
- W1936422345 hasAuthorship W1936422345A5003967548 @default.
- W1936422345 hasAuthorship W1936422345A5027935289 @default.
- W1936422345 hasAuthorship W1936422345A5089184763 @default.
- W1936422345 hasConcept C104317684 @default.
- W1936422345 hasConcept C109650736 @default.
- W1936422345 hasConcept C150194340 @default.
- W1936422345 hasConcept C181199279 @default.
- W1936422345 hasConcept C185592680 @default.
- W1936422345 hasConcept C190727270 @default.
- W1936422345 hasConcept C202199734 @default.
- W1936422345 hasConcept C202751555 @default.
- W1936422345 hasConcept C2777477808 @default.
- W1936422345 hasConcept C2779548794 @default.
- W1936422345 hasConcept C2780837634 @default.
- W1936422345 hasConcept C2781064554 @default.
- W1936422345 hasConcept C2781109383 @default.
- W1936422345 hasConcept C526171541 @default.
- W1936422345 hasConcept C55493867 @default.
- W1936422345 hasConcept C62231903 @default.
- W1936422345 hasConcept C86803240 @default.
- W1936422345 hasConcept C87644729 @default.
- W1936422345 hasConcept C89423630 @default.
- W1936422345 hasConcept C98274493 @default.
- W1936422345 hasConceptScore W1936422345C104317684 @default.
- W1936422345 hasConceptScore W1936422345C109650736 @default.
- W1936422345 hasConceptScore W1936422345C150194340 @default.
- W1936422345 hasConceptScore W1936422345C181199279 @default.
- W1936422345 hasConceptScore W1936422345C185592680 @default.
- W1936422345 hasConceptScore W1936422345C190727270 @default.
- W1936422345 hasConceptScore W1936422345C202199734 @default.
- W1936422345 hasConceptScore W1936422345C202751555 @default.
- W1936422345 hasConceptScore W1936422345C2777477808 @default.
- W1936422345 hasConceptScore W1936422345C2779548794 @default.
- W1936422345 hasConceptScore W1936422345C2780837634 @default.
- W1936422345 hasConceptScore W1936422345C2781064554 @default.
- W1936422345 hasConceptScore W1936422345C2781109383 @default.
- W1936422345 hasConceptScore W1936422345C526171541 @default.
- W1936422345 hasConceptScore W1936422345C55493867 @default.
- W1936422345 hasConceptScore W1936422345C62231903 @default.
- W1936422345 hasConceptScore W1936422345C86803240 @default.
- W1936422345 hasConceptScore W1936422345C87644729 @default.
- W1936422345 hasConceptScore W1936422345C89423630 @default.
- W1936422345 hasConceptScore W1936422345C98274493 @default.
- W1936422345 hasIssue "1" @default.
- W1936422345 hasLocation W19364223451 @default.
- W1936422345 hasOpenAccess W1936422345 @default.
- W1936422345 hasPrimaryLocation W19364223451 @default.